Plus Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 150,107, below the company average number of $155,749. Within the Healthcare sector Employees of 453 other companies have achieved higher revenue per employee. While Plus Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 3331 to 3413. Plus Therapeutics Inc has 28 employees.
In an evolving landscape of biopharmaceutical innovation, Plus Therapeutics Inc. is gripping attention, particularly with the recent appointment of new leadership within its CNSide Diagnostics subsidiary. This strategic move comes at a critical juncture for the company, as it contends with a notable decline in its stock performance. Over the past 90 days, the company’s share price has plummeted by 7.87%, raising questions about its market positioning and future growth prospects.Despite this dip in market confidence, Plus Therapeutics showcased a positive trend in operational productivity. The company s revenue per employee surged to $408,929 on a trailing twelve-month basis, indicating an increasing efficiency among its workforce. In the third quarter of 2024, Plus Therapeutics reported a year-on-year revenue growth of 17.42%, translating into a total revenue of $6 million. This upward trajectory highlights the company’s capacity to generate revenue and effectively leverage its human capital, even amidst external pressures.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
